<p><strong>Multiple Myeloma</strong>: Thalidomide in combination with&nbsp;dexamethasone&nbsp;is indicated for the treatment of patients with newly diagnosed&nbsp;multiple myeloma&nbsp;(MM).<br />
<br />
<strong>Erythema Nodosum Leprosum</strong>: Thalidomide is indicated for the acute treatment of the cutaneous manifestations of moderate to severe&nbsp;erythema&nbsp;nodosum leprosum (ENL). Thalidomide is not indicated as monotherapy for such ENL treatment in the presence of moderate to severe neuritis. Thalidomide is also indicated as&nbsp;maintenance therapy&nbsp;for prevention and suppression of the cutaneous manifestations of ENL recurrence</p>